Observational, Safety Study in Subjects Using Levemir (insulin detemir) for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 03 Nov 2016
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 11 Sep 2009 Actual patient number (1531) added as reported by ClinicalTrials.gov.
- 01 Dec 2008 Status changed from active, no longer recruiting to completed, according to clinicaltrials.gov.